1 – 34 of 34
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort
(
- Contribution to journal › Article
-
Mark
Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid : A secondary analysis of the Mega Donna Mega trial
(
- Contribution to journal › Article
-
Mark
Prognostic Value of Parenteral Nutrition Duration on Risk of Retinopathy of Prematurity : Development and Validation of the Revised DIGIROP Clinical Decision Support Tool
(
- Contribution to journal › Article
- 2022
-
Mark
Longitudinal Serum Metabolomics in Extremely Premature Infants : Relationships With Gestational Age, Nutrition, and Morbidities
(
- Contribution to journal › Article
-
Mark
Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity
(
- Contribution to journal › Article
- 2021
-
Mark
Systematic review of the healthcare cost of bronchopulmonary dysplasia
(
- Contribution to journal › Scientific review
-
Mark
Serum choline in extremely preterm infants declines with increasing parenteral nutrition
(
- Contribution to journal › Article
-
Mark
Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP
(
- Contribution to journal › Article
-
Mark
Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels with Retinopathy of Prematurity in Preterm Infants
(
- Contribution to journal › Article
-
Mark
Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity among Preterm Infants
(
- Contribution to journal › Article
-
Mark
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity : A Randomized Clinical Trial
(
- Contribution to journal › Article
- 2020
-
Mark
Unpasteurised maternal breast milk is positively associated with growth outcomes in extremely preterm infants
(
- Contribution to journal › Article
-
Mark
IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants
(
- Contribution to journal › Article
- 2019
-
Mark
C-Peptide Suppression during Insulin Infusion in the Extremely Preterm Infant Is Associated with Insulin Sensitivity
(
- Contribution to journal › Article
- 2018
-
Mark
Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity
(
- Contribution to journal › Article
-
Mark
Photoreceptor glucose metabolism determines normal retinal vascular growth
(
- Contribution to journal › Article
- 2017
-
Mark
IGF-1 as a Drug for Preterm Infants : A Step-Wise Clinical Development
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.
(
- Contribution to journal › Article
-
Mark
IGF-I in the clinics : Use in retinopathy of prematurity
(
- Contribution to journal › Article
-
Mark
Role of Insulinlike Growth Factor 1 in Fetal Development and in the Early Postnatal Life of Premature Infants
(
- Contribution to journal › Scientific review
-
Mark
Insulin-like growth factor 1 has multisystem effects on fetal and preterm infant development.
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Early Surge in Circulatory Adiponectin Is Associated With Improved Growth at Near Term in Very Preterm Infants.
(
- Contribution to journal › Article
-
Mark
Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.
(
- Contribution to journal › Article
- 2014
-
Mark
Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age.
(
- Contribution to journal › Article
- 2013
-
Mark
Circulatory insulin-like growth factor-I and brain volumes in relation to neurodevelopmental outcome in very preterm infants.
(
- Contribution to journal › Article
-
Mark
WINROP Identifies Severe Retinopathy of Prematurity at an Early Stage in a Nation-Based Cohort of Extremely Preterm Infants
(
- Contribution to journal › Article
-
Mark
Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety
(
- Contribution to journal › Article
- 2012
-
Mark
Low Postnatal Serum IGF-I levels is Associated with Bronchopulmonary Dysplasia (BPD).
(
- Contribution to journal › Article
- 2011
-
Mark
Influence of Insulin-Like Growth Factor-I and Nutrition during Phases of Postnatal Growth in Very Preterm Infants.
(
- Contribution to journal › Article
-
Mark
Postnatal Decrease in Circulating Insulin-Like Growth Factor-I and Low Brain Volumes in Very Preterm Infants.
(
- Contribution to journal › Article
- 2009
-
Mark
Fresh-frozen Plasma as a Source of Exogenous Insulin-like Growth Factor I in the Extremely Preterm Infant.
(
- Contribution to journal › Article
-
Mark
Lower postnatal serum IGF-I levels in very preterm boys than in girls - association with morbidity
(
- Contribution to journal › Published meeting abstract
-
Mark
A Pharmacokinetic and Dosing Study of Intravenous Insulin-Like Growth Factor-I and IGF-Binding Protein-3 Complex to Preterm Infants.
(
- Contribution to journal › Article
- 2008
-
Mark
Pharmacokinetic study of recombinant human (rh) insulin-like growth factor I/rhIGFBP-3 complex administered to very low birth weight infants
(
- Contribution to journal › Published meeting abstract